Vanderbilt Psychiatric Hospital
Nashville, Tennessee 37212-8645
3 studies enrolling now · 17 studies all time
What they study most
Alzheimer Disease, Bipolar Disorder, Cannabis Use, Central Nervous System Diseases, Cognition, Cognitive Decline, Cognitive Impairment Associated With Schizophrenia, Depression, Depressive Disorder, Depressive Disorder, Treatment-Resistant, Down Syndrome, Gait Impairment
Studies at this site
- A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4) — Recruiting now
- Precision Brain Stimulation to Reduce Cannabis Craving in Schizophrenia — Recruiting now
- Dopaminergic Dysfunction in Late-Life Depression — Completed
- Depressed Mood Improvement Through Nicotine Dosing-3 (Depressed MIND3) Extension — Completed
- Estimating and Reducing the Cardiovascular Risk of Patients With Schizophrenia Drugs From Lipid Measures and Ischemic Electrocardiographic Changes — Stopped early
- High Dose Risperidone Consta for Patients With Schizophrenia With Poor Response to Risperidone — Completed
- Accelerated DMN-Targeted cTBS to Modulate DMN Connectivity — Enrolling by invitation
- Depressed Mood Improvement Through Nicotine Dosing 2 — Completed
- Nicotine Treatment of Cognitive Decline in Down Syndrome — Completed
- Effects of Transdermal Nicotine on Response Inhibition to Emotional Cues in Schizophrenia — Stopped early
- Connectivity Affecting the Antidepressant REsponse Study — Completed
- Safety and Efficacy of Cariprazine in Patients With Schizophrenia — Completed
- Depressed Mood Improvement Through Nicotine Dosing (Depressed MIND Study) — Completed
- Effects of Cerebral Hypoperfusion and Its Reversal on Late-Life Depression — Stopped early
- Safety and Cognitive Function Study of EVP-6124 in Patients With Schizophrenia — Completed
- Changes in Heart Rhythms Associated With Antipsychotic Drug Treatment — Completed
- Study to Evaluate the Safety and Efficacy of MEM 3454 as Adjunctive Treatment in Combination With a Preexisting Antipsychotic in Patients With Cognitive Impairment Associated With Schizophrenia — Status unconfirmed